Streetbeat News

Products Services

AAPL

Foxconn and Pegatron, key suppliers for Apple, are experiencing difficulties with iPhone orders, according to DigiTimes. This situation could potentially impact Apple's supply chain and its ability to meet demand for iPhones.

Portfolio Pulse from Benzinga Newsdesk

February 01, 2024 | 1:58 pm

AAPL

According to DigiTimes, MacBook shipments are expected to increase in 2024, as indicated by sources. This news suggests a positive outlook for Apple's MacBook product line, potentially reflecting increased demand or successful marketing strategies.

Portfolio Pulse from Benzinga Newsdesk

February 01, 2024 | 1:56 pm

AA

Alcoa has entered into an agreement to supply Nexans with low-carbon aluminum rod, incorporating metal from the ELYSIS technology. This technology, a partnership initiative, aims to eliminate direct greenhouse gas emissions from the traditional aluminum smelting process, replacing them with oxygen as a byproduct. The use of ELYSIS technology ensures that the aluminum rod produced will have significantly lower CO2 emissions.

Portfolio Pulse from Benzinga Newsdesk

February 01, 2024 | 1:49 pm

ASNS

Actelis Networks, Inc. has received an order to provide an Intelligent Traffic Management System for the City of Napa. This development highlights Actelis' role in enhancing urban infrastructure through advanced technology solutions.

Portfolio Pulse from Benzinga Newsdesk

February 01, 2024 | 1:48 pm

ELTX

Elicio Therapeutics has initiated the Phase 2 study of its product ELI-002 7P by dosing the first patient. This marks a significant step in the development of ELI-002 7P, potentially impacting the company's future prospects.

Portfolio Pulse from Benzinga Newsdesk

February 01, 2024 | 1:47 pm

CMND

Clearmind Medicine has entered into a long-term licensing agreement with BIRAD for its cocaine addiction treatment, which has shown a significant decrease in cocaine craving. Financial terms of the agreement were not disclosed.

Portfolio Pulse from Benzinga Newsdesk

February 01, 2024 | 1:44 pm

CYDY

CytoDyn has submitted a clinical protocol to the FDA and initiated a pre-clinical study targeting glioblastoma. This marks a significant step in the company's efforts to develop treatments for this aggressive form of brain cancer.

Portfolio Pulse from Benzinga Newsdesk

February 01, 2024 | 1:44 pm

BX

COST

ZBH

On CNBC's 'Halftime Report Final Trades,' analysts highlighted Blackstone Inc. (BX) despite mixed Q4 2023 results, Costco Wholesale Corporation (COST) implementing new measures to curb unauthorized access, and Zimmer Biomet Holdings, Inc. (ZBH) ahead of its expected positive Q4 earnings report. Blackstone missed revenue expectations, Costco is trialing a new scanning system, and Zimmer Biomet is anticipated to report increased earnings and revenue.

Portfolio Pulse from Avi Kapoor

February 01, 2024 | 1:33 pm

NVDA

PLUS

ePlus has introduced AI Ignite, a suite of services designed to support organizations in implementing and managing AI infrastructure. This includes design and deployment services tailored to specific AI use cases, advanced support for NVIDIA DGX BasePOD, a Storage-as-a-Service (STaaS) offering for AI workloads, and data modernization services to align data strategy with AI goals. ePlus, as a Certified NVIDIA DGX Ready Managed Services Provider, emphasizes its expertise in managing NVIDIA DGX environments.

Portfolio Pulse from Benzinga Newsdesk

February 01, 2024 | 1:32 pm

ICU

SeaStar Medical has been granted a Canadian patent for its Cytopheretic Device technology, which is a significant development for the company. This patent covers broad claims related to the technology, potentially strengthening SeaStar Medical's position in the medical device market.

Portfolio Pulse from Benzinga Newsdesk

February 01, 2024 | 1:30 pm